The global urinary incontinence market size was valued at USD 10.9 billion in 2021 and is expected to surpass USD 19.1 billion by 2030, expanding at a CAGR of 6.5% during the forecast period, 2022–2030. The growth of the market is attributed to the wide prevalence of the disorder among the geriatric population and rising spending on the disorder treatment.
Urinary incontinence is a condition of an involuntary urine leakage primarily caused by a broken sphincter or a malfunctioning bladder. The disorder is also known as an overactive bladder as it is closely associated with people having bladder control issues due to weakness of bladder muscles or nerves. Urine leaking problem is most commonly occurred among the older people, especially women and the problem may arise even on exerting some pressure on the bladder due to laughing, coughing, sneezing, or light physical exercises. To women, the cause of the disorder may vary and can happen due to certain and unique body functions such as pregnancy, childbirth, and menopause, which results in weakening muscles and nerves around the bladder. However, being overweight can be a key factor in causing the disorder for both men and women. The severity level of the disorder may differ from one person to another depending on the types of causes, types of the disorder, and age factors. Using appropriate treatment methods, most of urinary incontinence cases can be controlled and even cured. Several devices are available for the treatment and the devices can assist patients for effective management of the disorder.
The COVID-19 pandemic had posed a threat to the market expansion as almost all medical and healthcare institutions including hospitals and clinics have focused on tackling the emerging healthcare burden of coronavirus cases. Patients with urinary incontinence preferred to continue home treatment and avoid visiting hospitals to avoid the risks of the virus spreading. As per several global reports, the number of patients having outpatient tests and treatments and demand for surgical treatment for various kidney and bladder stones had substantially declined during the pandemic.
Market Trends, Drivers, Restraints, and Opportunities
- Rising geriatric population and wide occurrence of urinary disorders among the women population globally are key factors driving the market.
- Rapid development of advanced devices for urinary incontinence treatment and rising demand for minimally invasive operations among patients present other key drivers of the market.
- Growing awareness regarding the effective treatment methods for the disorder and increasing healthcare spending are expected to boost the market during the forecast period.
- Lack of awareness of effective treatment methods and continuation of traditional treatment methods act as major hurdles that can hamper the market.
- Technological advancements for the development of innovative treatment devices and user-friendly disposable products are likely to create several growth opportunities for the market.
Scope of the Report
The report on the global urinary incontinence market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Urinary Incontinence Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2021 |
Historic Data | 2019–2020 |
Forecast Period | 2022–2030 |
Segmentation | Types (Urge Urinary Incontinence, Functional Urinary Incontinence, Stress Urinary Incontinence, and Overflow Urinary Incontinence), Products (Devices and Disposables), and End-users (Home Care, Hospitals & Clinics, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation. |
Market Segment Insights
Stress urinary incontinence segment holds a dominant market share
Based on types, the global urinary incontinence market is divided into urge urinary incontinence, functional urinary incontinence, stress urinary incontinence, and overflow urinary incontinence. The stress urinary incontinence (SUI) segment held a dominant market share in 2021 and is expected to expand at a rapid pace during the forecast period owing to rising incidences of the urinary incontinence type among a large number of the women population worldwide. As per global reports, around 50% of women having urinary incontinence disorder are likely to experience SUI.
Higher rate of disposables consumption drives the disposables segment
In terms of products, the market is bifurcated into devices and disposables. The disposables segment is anticipated to hold a key share of the market in the coming years due to a higher rate of disposables consumption among patients and the availability of low-price disposable treatment products. On the other hand, the devices segment is anticipated to register a robust growth rate in the coming years due to rising spending on advanced device treatment methods due to high rate of treatment success.
High admission rate of the patients boosts the hospitals & clinics segment
On the basis of end-users, the global urinary incontinence market is segregated into home care, hospitals & clinics, and others. The hospitals & clinics segment constituted a dominant market share in 2021 and is projected to register a considerable CAGR during the forecast period due to high admission rate of the patients to hospitals and frequent patient visits to hospitals for treatment. The presence of various specialized medical staff and technicians for the diagnosis and treatment of the disorders along with the availability of advanced treatment devices in hospitals and clinics further boost the segment.
North America is anticipated to constitute a key market share
In terms of regions, the global urinary incontinence market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the presence of a wide pool of geriatric population and rising cases of urinary incontinence in the region. The early adoption of novel devices for the treatment of the disorder and rising spending in the healthcare sector present other key drivers of the regional market. On the other hand, the Asia Pacific market is anticipated to expand at a rapid pace during the forecast period owing to increasing awareness about the advanced treatment methods for the disorder and rising healthcare expenditure among a large portion of the population in the region.
Segments
Segments Covered in the Report
The global urinary incontinence market has been segmented on the basis of
Types
- Urge Urinary Incontinence
- Functional Urinary Incontinence
- Stress Urinary Incontinence
- Overflow Urinary Incontinence
Products
End-users
- Home Care
- Hospitals & Clinics
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Medtronic plc
- Becton, Dickinson and Company
- Teleflex Incorporated
- Caldera Medical
- Coloplast A/S
- ConvaTec Group plc
- Cook Group Inc.
- Johnson and Johnson
- Laborie Medical
- Asahi Kasei Corporation
- Georgia-Pacific LLC
- Kimberly-Clark Corporation
- Berry Global Inc.
- First Quality Enterprises, Inc.
- Freudenberg & Co. KG
- Unicharm Corporation
- Ahlstrom-Munksjo
- Domtar Corporation
Competitive Landscape
Key players competing in the global urinary incontinence market are Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation.